These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7300757)

  • 1. Compliance with anticoagulant drug therapy: a study on patients with prosthetic heart valves.
    Howard AF; Frewin DB; Leonello PP; Taylor WB
    Med J Aust; 1981 Sep; 2(6):274-6. PubMed ID: 7300757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Approaches for prescribing anticoagulant therapy to patients with prosthetic heart valves].
    Gorbunova EV
    Klin Med (Mosk); 2013; 91(2):49-52. PubMed ID: 23718066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
    Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
    J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study.
    Lee HL; Kan CD; Yang YJ
    Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation therapy in patients with prosthetic heart valves.
    Douketis JD
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):436-8. PubMed ID: 17679917
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the patient receiving Coumadin anticoagulant therapy.
    Rada RE; Lamberghini F
    CDS Rev; 1997 Sep; 90(6):34-8. PubMed ID: 9594727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prosthetic valve thrombosis: twenty-year experience at the Montreal Heart Institute.
    Dürrleman N; Pellerin M; Bouchard D; Hébert Y; Cartier R; Perrault LP; Basmadjian A; Carrier M
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1388-92. PubMed ID: 15115997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
    Toyohira H; Nakamura K; Kariyazono H; Yamada K; Moriyama Y; Shimokawa S; Saigenji H; Taira A
    Kyobu Geka; 1995 Aug; 48(9):749-55. PubMed ID: 7564036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute thrombosis of a prosthetic mitral valve: a lesson in anticoagulation.
    Sharma R; Ooi A; Jokhi P; Tsang GM; Simpson IA
    J Am Soc Echocardiogr; 2007 Aug; 20(8):1010.e7-9. PubMed ID: 17555942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve?
    Bayliss A; Faber P; Dunning J; Ronald A
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):390-6. PubMed ID: 17669876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H;
    Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the compliance of antihypertensive drugs in patients with hypertension].
    Guo H; He H; Jiang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):418-20. PubMed ID: 11851054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Splenic infarction after warfarin discontinuation during atrial fibrillation].
    Trappolini M; Scorzai A; Loguercio V; Stoppo M; Sebastianelli A; Iannotta M; Del Porto F; Proietta M; Aliberti G
    Clin Ter; 2008; 159(6):435-7. PubMed ID: 19169604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The St Jude medical valve - the Australian experience.
    Hunt D; Sloman G; Sutton L
    Med J Aust; 1981 Sep; 2(6):276-8. PubMed ID: 7300758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of prescribing low-dose drug therapy for older people.
    Rochon PA; Clark JP; Gurwitz JH
    CMAJ; 1999 Apr; 160(7):1029-31. PubMed ID: 10207345
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
    CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of magnetic resonance imaging for managing patients with prosthetic carbon valve in the mitral position].
    Koito H; Imai Y; Suzuki J; Ohkubo N; Nakamura C; Takahashi H; Iwasaka T; Inada M
    J Cardiol; 1997 Nov; 30(5):251-63. PubMed ID: 9395956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.